[
    [
        {
            "time": "2020-05-29",
            "original_text": "王晶翼获科伦千万股权激励，本土药企为留人才放大招！恒瑞、信达、基石……谁的激励更丰厚？",
            "features": {
                "keywords": [
                    "股权激励",
                    "科伦",
                    "恒瑞",
                    "信达",
                    "基石"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "王晶翼获科伦千万股权激励，本土药企为留人才放大招！恒瑞、信达、基石……谁的激励更丰厚？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-29",
            "original_text": "1万年薪却能得9亿分红？299家A股药企高管薪酬大揭秘！迈瑞、药明争抢榜首，恒瑞仍保持低调",
            "features": {
                "keywords": [
                    "高管薪酬",
                    "迈瑞",
                    "药明",
                    "恒瑞"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "1万年薪却能得9亿分红？299家A股药企高管薪酬大揭秘！迈瑞、药明争抢榜首，恒瑞仍保持低调",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-29",
            "original_text": "金徽酒易主复星系 “西北王”有望加速布局全国市场？控制人变化",
            "features": {
                "keywords": [
                    "金徽酒",
                    "复星系",
                    "控制人变化"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "金徽酒易主复星系 “西北王”有望加速布局全国市场？控制人变化",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-29",
            "original_text": "复星医药旗下抗恶性肿瘤新药获美FDA临床试验批准",
            "features": {
                "keywords": [
                    "复星医药",
                    "FDA",
                    "临床试验",
                    "新药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药旗下抗恶性肿瘤新药获美FDA临床试验批准",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-05-29",
            "original_text": "恒指跌0.73%报22964.15点汽车板块领跌",
            "features": {
                "keywords": [
                    "恒指",
                    "汽车板块",
                    "下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "指数",
                    "汽车"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒指跌0.73%报22964.15点汽车板块领跌",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-29",
            "original_text": "中生制药绩后倒升逾8%冠蓝筹 获瑞信升至跑赢大市",
            "features": {
                "keywords": [
                    "中生制药",
                    "瑞信",
                    "跑赢大市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中生制药绩后倒升逾8%冠蓝筹 获瑞信升至跑赢大市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-29",
            "original_text": "郭广昌再度“喝酒” 复星系加速白酒布局",
            "features": {
                "keywords": [
                    "郭广昌",
                    "复星系",
                    "白酒"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "郭广昌再度“喝酒” 复星系加速白酒布局",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]